# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3399404 | Binding | Inhibition of DHFR (unknown origin) | Homo sapiens | 4 | ALA3396974 | single protein format | Scientific Literature | |
2. | ALA3119714 | Functional | Ratio of 5-FU LC50 to compound LC50 for human prostate cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
3. | ALA3119715 | Functional | Ratio of 5-FU LC50 to compound LC50 for human breast cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
4. | ALA3119716 | Functional | Ratio of 5-FU LC50 to compound LC50 for human ovarian cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
5. | ALA3119717 | Functional | Ratio of 5-FU LC50 to compound LC50 for human renal cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
6. | ALA3119718 | Functional | Ratio of 5-FU LC50 to compound LC50 for human CNS cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
7. | ALA3119719 | Functional | Ratio of 5-FU LC50 to compound LC50 for human melanoma cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
8. | ALA3119720 | Functional | Ratio of 5-FU LC50 to compound LC50 for human colon cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
9. | ALA3119721 | Functional | Ratio of 5-FU LC50 to compound LC50 for human leukemia cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
10. | ALA3119722 | Functional | Ratio of 5-FU LC50 to compound LC50 for human non-small cell lung cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
11. | ALA3119723 | Functional | Ratio of 5-FU TGI to compound TGI for human prostate cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
12. | ALA3119724 | Functional | Ratio of 5-FU TGI to compound TGI for human breast cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
13. | ALA3119725 | Functional | Ratio of 5-FU TGI to compound TGI for human ovarian cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
14. | ALA3119726 | Functional | Ratio of 5-FU TGI to compound TGI for human renal cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
15. | ALA3119727 | Functional | Ratio of 5-FU TGI to compound TGI for human colon cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
16. | ALA3119728 | Functional | Ratio of 5-FU TGI to compound TGI for human CNS cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
17. | ALA3119729 | Functional | Ratio of 5-FU TGI to compound TGI for human melanoma cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
18. | ALA3119730 | Functional | Ratio of 5-FU TGI to compound TGI for human non-small cell lung cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
19. | ALA3119731 | Functional | Ratio of 5-FU TGI to compound TGI for human leukemia cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature | |
20. | ALA3119732 | Functional | Ratio of 5-FU GI50 to compound GI50 for human breast cancer cells | Homo sapiens | 3 | ALA3112482 | cell-based format | Scientific Literature |